TGF-beta(Smad)

TGF-beta(Smad)

The pleiotropic protein known as transforming growth factor-beta (TGF-) is a member of a superfamily that controls several cellular processes, including growth, development, and differentiation. The Smad proteins, which are the intracellular TGF-beta signaling effectors, are activated by receptors and move into the nucleus where they control transcription. Although this pathway is fundamentally straightforward, cooperation with sequence-specific transcription factors, combinatorial interactions in the heteromeric receptor and Smad complexes, receptor-interacting and Smad-interacting proteins, and other factors enable significant versatility and diversity of TGF-beta family responses. Smad activation and function are further regulated by other signaling pathways.
Additionally, TGF-beta receptors activate Smad-independent pathways that enable Smad-independent TGF-beta responses in addition to regulating Smad signaling. Abnormal TGF- signaling has been linked to a number of illnesses, including cancer, cardiovascular disease, and fibrosis. Consequently, it is acknowledged that the TGF-signaling pathway is a potential drug target.

TGF-beta(Smad) related products

Structure Cat No. Product Name CAS No. Product Description
V4080 SRI-011381 1629138-41-5 SRI-011381 (SRI011381) is a novel and potent agonist of the TGF-beta signaling pathway with the potential for treatment of Alzheimers disease.
V67545 SRI-011381 hydrochloride 2070014-88-7 SRI-011381 HCl is an orally bioavailable activator of the TGF-β signaling pathway with neuro-protective (neuro-protection) effects.
V3718 TP0427736 864374-00-5 TP0427736 is a novel, potent and selective inhibitor ofALK5 kinase with IC50 value of 2.72 nM andappropriate in vitro and in vivo profiles.
V67557 Trabedersen (AP 12009) 925681-61-4 Trabedersen (AP 12009) is an antisense oligodeoxynucleotide that specifically inhibits TGF-beta2 (TGF-beta/Smad).
Contact Us Back to top